Imidazolium‐Based Lipid Analogs as Lipofection Reagents
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Marco Pierau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Organisch-Chemisches Institut, Universität Muenster, Muenster, Germany. Hauptthemen laut MEDLINE: Imidazoles, Transfection, Lipids, Gene Transfer Techniques. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A.J. thanks the German Research Foundation (DFG) for the financial support (JU 2966/2-2, GRK2515/1-2 and EXC 2180 - 390900677). C.D. thanks the German Research….
Abstract (Originalsprache)
Three imidazolium‐based lipid analogs with varying degrees of saturation were synthesized and evaluated for their potential to enhance gene transfer in the 1321N1 and HEK‐293FT cell lines. The analogs were incorporated into DPPC/DOPE‐based liposomes and compared with two established transfection reagents, Lipofectamine3000 and FuGENE 4 K. Cytotoxicity assessments, as determined by lactate dehydrogenase assays, revealed a lower toxicity profile for the fully saturated compound 1 compared with its mono‐ ( 2 ) and di‐unsaturated ( 3 ) counterparts. Notably, longer incubation times (24 h) amplified cytotoxic responses, with C 17 H 31 ‐IMeNMe 3 ( 3 ) displaying the highest cell damage. Despite elevated toxicity relative to commercial reagents, compound 3 successfully delivered plasmid DNA using a PiggyBac transposon system, producing stable transfected cell lines after extended culture periods. C 15 H 31 ‐IMeNMe 3 ( 1 ) achieved stable transfection but required longer colony expansion than the commercial controls, whereas C 17 H 33 ‐IMeNMe 3 ( 2 ) did not yield transfected lines under the conditions tested. Overall, these results suggest that structural modifications, particularly the length of the alkyl chain and the number of double bonds, impact both cytotoxicity and transfection efficiency. The findings underscore the importance of rational lipid design, as stronger membrane interactions can enhance uptake while potentially heightening adverse effects. This study informs future development of safer, more effective nonviral delivery vectors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organisch-Chemisches Institut, Universität Muenster, Muenster, Germany.
- Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Cluster of Excellence iFIT (EXC 2180) 'Image-guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, G…
ORCID-Profile: Ronewa Nematswerani, Calvin Dunker
Förderung
- A.J. thanks the German Research Foundation (DFG) for the financial support (JU 2966/2-2, GRK2515/1-2 and EXC 2180 - 390900677). C.D. thanks the German Research…
Zitieren
APA
Pierau, M., Nematswerani, R., Dunker, C., Glorius, F., & Junker, A. (2025). Imidazolium‐Based Lipid Analogs as Lipofection Reagents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70076
Vancouver
Pierau M, Nematswerani R, Dunker C, Glorius F, Junker A. Imidazolium‐Based Lipid Analogs as Lipofection Reagents. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70076
BibTeX
@article{Pierau2025,
author = {Pierau, Marco and Nematswerani, Ronewa and Dunker, Calvin and Glorius, Frank and Junker, Anna},
title = {Imidazolium‐Based Lipid Analogs as Lipofection Reagents},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70076}
}
EUVIMED